NCT05214612View on ClinicalTrials.gov

Predictors and Prognostic Factors of Myasthenia Gravis Outcome

RecruitingOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

January 1, 2022

Primary Completion Date

December 31, 2024

Study Completion Date

March 31, 2025

Conditions
Myasthenia GravisAutoimmune Diseases of the Nervous SystemNeuromuscular Junction DiseasesThymomaThymus HyperplasiaNervous System DiseasesMyasthenia Gravis, GeneralizedMyasthenia Gravis, OcularMyasthenia Gravis CrisisMyasthenia Gravis With Exacerbation (Disorder)Myasthenia Gravis, Adult FormMyasthenia Gravis, Juvenile Form
Interventions
COMBINATION_PRODUCT

Drug treatment of myasthenia gravis and treatment of crisis

Patients with myasthenia gravis who are receiving medical treatment and treatment of crisis as plasmapheresis

Trial Locations (1)

71515

RECRUITING

Assiut University, Asyut

All Listed Sponsors
lead

Assiut University

OTHER